1/122
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
Theca Cells
LH stimulates androgen production
upon binding to LH receptor, cholesterol goes through synthesis pathway (including progestin synthesis) and ends with testosterone
lacks aromatase, cannot convert to estrogens as of yet
testosterone then gets shuttled across blood vessels to get to granulosa cells
these hormones are v lipophilic, can cross v easily
LH
maintains corpus luteum which will then release tons of E/P for conception
surge triggers ovulation
supports theca cells in the ovary
stimulates ovarian hormone production
FSH
stimulates growth of ovarian follicles and granulosa cell proliferation
Granulosa Cells
FSH stimulates aromatase expression
these cells nurture the egg
binding of FSH receptor stimulates aromatase production → testosterone can be converted to E
this serves as a T sink, huge concentration gradient
Ovarian Cycle → Follicular Phase
characterized by rising e and low p
follicular growth stimulated by FSH → mature follicle produces e
primordial → primary → secondary → tertiary → Graafian follicle
consists of the egg/ovum, granulosa cells surrounding that, basement membrane around that, then theca cells
FSH initially high due to lack of e/p (no cl), but then drops as e rises
no corpus luteum producing p just yet
Ovarian Cycle → Ovulation Phase
peak in GnRH and LH
rising e stimulates GnRH which then stimulates LH surge
normally has a - feedback effect, but when concentration of e is high enough for a significant amount of time, it starts inducing + feedback
mediated by kispeptin
LH surge causes ovulation → egg released
Ovarian Cycle → Luteal Phase
characterized by high e/p
corpus luteum forms from post-ovulatory follicle → drives production of e/p
LH or hCG required for maintenance
maintains uterine tissue to prep for pregnancy
LH/FSH fall due to - feedback from e/p
if no pregnancy/no hCG (produced by embryo) → cl undergoes luteolysis → corpus albicans
p starts dropping
at the end, lack of sex steroids removes - feedback and increases GnRH
LH/FSH start driving recruitment of new follicle for the next cycle
Uterine Cycle → Proliferative Phase
e from follicular cells starts to stimulate endometrial lining proliferation until corpus luteum fully forms
e also induced p receptor production in endometrium
Uterine Cycle → Secretory Phase
p drops e receptor expression → dont want to be in proliferative phase anymore
nutrients start to be secreted in preparation for embryo implantation
p also stimulates spiral artery growth and increases blood flow
Uterine Cycle → Menstrual Phase
lack of hCG (would come from embryo, normally maintains cl) leads to loss of e/p
lack of - feedback leads GnRH/FSH/LH to rise
recruiting new follicles
p no longer able to maintain uterine lining
p is vasodilating → loss leads to massive vasoconstriction via spiral arteries → ischemia/tissue death → sloughing of the endometrium → bleeding
Estrogen on Cervix
reduces viscosity of the cervical mucus → easier for sperm to enter
most viscous/permissive to sperm when ovulating
further increases quantity and pH (good environment for sperm)
Progesterone on Cervix
increases mucus viscosity
decrease pH
Where is estrogen proliferative?
both breast and uterus
Where is progesterone proliferative?
breast
alternatively protective in uterus
s/sx of menopause
loss of protective effects → chd rates increase, osteo and bone fracture incidence rise
hot flashes → vascular instability, issues with the brain
high fsh/lh mess with the hypothalamus which is where our temperature control lives
urogenital system atrophy → can have painful intercourse
sex drive decrease
body mass increases while muscle density decreases
leydig cells
sertoli cells
FSH stimulates androgen binding protein synthesis + supports spermatogenesis
binding to FSHR → androgen binding protein → high affinity for t
abg+t will get shuttled into lumen → increases t concentration → integral for spermatogenesis!
also makes a t sink → less t in the sertoli cell, more in the lumen
note that e is also important for the synthesis of enzymes that will produce t
can also produce inhibins which participate in negative feedback loop
male external genitalia development
SRY gene is present on y chromosome → initiates testis development
if sry not present or malfunctioning → lack of testes → no t → no dht → female external genitalia despite xy chromosomal sex
testes wil then start producing anti-mullerian hormone AMH and t
AMH inhibits mullerian ducts and causes them to disappear
this blocks the development of the uterus, fallopian tubes, and upper third of the vagina
the preserved wolffian tubes become the epididymis, vas deferens, and prostate
once t enters systemic circulation, it reaches the skin around the genitalia and activates androgen receptors
these cells have 5alpha r and produce dht → powerfully contribute to further development
dht will help develop the rest of the penis and scrotum
Define pubarche, adrenarche and
hormonal contraception
manipulating the menstrual cycle
mimicking luteal phase so body thinks youre alr pregnant and it doesnt have to do anything
also target LH spike to prevent or delay ovulation
emergency contraception
block or delay LH surge/ovulation
infertility
inability to conceive after 12 months of trying (<35) or 6 months of trying (>35)
goal is to normalize and induce ovulation → synch up cycle with introduction of sperm
estrogen positive feedback
if e concentration is high for a prolonged period of time, it activates kispeptin and results in + feedback which will trigger ovulation
estrogen ses
breast tenderness/enlargement → stimulates breast tissue growth
headache
fluid retention/bloating
nausea
cv complications → clots, stroke, heart attack
increases clotting factor production from liver
endometrial hyperplasia
cancer
progestin ses
menstrual irregularities
acne
tiredness
vaginal dryness/atrophy
vte
breast cancer
mood changes
lower bmd → increased risk with implant
Combined Oral Contraceptives
low levels of e/p provide negative feedback onto lh/fsh → prevent follicle development, no rupture no pregnancy
p also thickens cervical mucus → prevents sperm from entering cervix
p also also thins the uterine lining → endometrium too thin for successful implantation
when would patch be preferable?
patch skips first pass metab → prevents increase in liver proteins
beneficial for older pts who may be more sensitive to changes in drug elimination and such
ella moa
agonism at the hypothalamus → blocks/delays LH surge via - feedback
antagonism at the ovary → blocks follicle rupture/ovulation
mifepristone
PR antagonism
used for medication abortion
lack of p to help maintain endometrium for embyro and all the other good stuff → expulsion within hours
misoprostol
prostaglandin analog
promotes contraction of uterus → results in expulsion of fetus
clomipheme
SERM for infertility
er antagonist at the hypothalamus → blocks negative feedback effect → GnRH pulse frequency increases → increased FSH/LH → FOLLICLE STIMULATIONN
works to stimulate multiple follicles at once
also blocks e in the uterus, thins endometrial lining → honestly problematic for pregnancy, as fertilization may occur but implantation may not
er agonist in the ovaries → increases FSH-mediated stimulation of LH receptors
letrozole
aromatase inhibitor for infertility
blocks estrogen production from testosterone, reducing negative feedback effect → increased LH → FOLLICLE STIMULATIONNN
pk changes in pregnant pts
increased Vd, increased fluid volume, greater clearance, increased liver protein production
they clear drugs mega fast!!!! and the properties of those drugs will change within them as well
can also have decreased gastric emptying and small intestinal motility → overall decreased drug absorption
how to treat ed
block cGMP or decrease ca → net vasodilation
preeclampsia
new onset htn with proteinuria or end organ damage w/wo proteinuria
related to the failure to remodel the spiral arteries into/out of the placenta
fetus cant get all of the nutrients that it needs
poor development of feto-placental vasculature
timing usually occurs after 20 weeks
preeclampsia ppx
ASA 81-162mg at NIGHT starting ~12 weeks until delivery
ideally start prior to 16 weeks, but can initiate before 28 weeks
preeclampsia diagnosis
proteinuria with SBP >140 or DBP >90, confirm twice
if no proteinuria, requires some sign of end organ damage
preeclampsia with severe features diagnosis
proteinuria w/ SBP >160 or DBP >110 OR SBP >140 or DBP >90 with one of the following features of end organ damage
new onset cerebral or visual changes
platelets <100k
lfts 2x nl
pulmonary edema
scr >1.1 → pregnant pts have LOW scr bc they clear so well, normally within 0.4-0.5
how old do we want baby to be for delivery
try to get baby to term ~37 week but hopefully 39 weeks → better brain development, baby adjusts better to ex-utero
may delivery as early as 34 weeks when necessary
serious adverse effects of chc → ACHES
Abdominal pain → ectopic pregnancy
Chest pain → PE
Headache → stroke
Eye problems → thrombosis of retinal blood vessels
Severe leg pain → DVT
missed dose of chc
if you miss more than 4-5 days, just use backup for a week
for pop, missing just one dose also can require backup for a week
when to resume chc after ella
if resuming hormonal contraception, wait 5 days
if pt has missed more than or equal to 3 days of bc, can start the day of
USE BACK UP CONTRACEPTION FOR 12 DAYS TOTALL
during the 5 days you dont have the coc on board, need it
then when you have the coc, need to do another 7 before full effect
when to resume bc after plan b
can resume same day
how to know if pt not pregnant
≤7 days after the start of normal menses
No sexual intercourse since last menses
Correct and consistent use of reliable contraception
≤7 days after pregnancy loss or induced abortion
<4 weeks postpartum
<6 months postpartum, amenorrheic, and exclusively breastfeeding or ≥85% of feeds are breastfeeds
medication abortion within first trimester
for use within first 10 weeks
mifepristone + misoprostol
mif first then miso after a day → thin that lining to prevent implantation, then increase expulsion
misoprostol alone
Medication Abortion in the 2nd Trimester
meds off label to induce labor
procedural abortion in first trimester
manual vacuum aspiration
electrical vacuum aspiration
dilation and crettage
procedural abortion in second trimester
dilation and evacuation
how to follow up for abortion
medical abortion requires follow up after 7-14 days to confirm abortion
can do serum hcg before treatment then repeat on day 8
ultrasound at clinic on day 8
home pregnancy test after 4 weeks
when to start bc after medication abortion
can start on day of mif administration
pill, patch, ring, dmpa, implant
can start after 5-9 days of mif administration
iud
diagnostic labs for menopause
high fsh, low e
when is MHT risk benefit ratio positive
for pts <60 within 10 years of menopause
when is MHT risk benefit ratio negative
for pts >60 or 10-20 years after menopause onset\
higher risk of coronary heart disease, stroke, vte, dementia
thyroid hormone and bone homeostasis
th important for linear growth of bone → affect both oc and ob
high th → osteo/high bone turnover
low th → brittle bone/low turnover
th hormone synthesis
Iodide Uptake → na/i symporter shuttles charged iodide into lumen of follicular cell
Oxidation → charged iodide converted into iodine via thyroid peroxidase TPO living on apical membrane
Iodide Attachment → thyroglobin has tons of tyrosine residues on it, TPO also attaches iodine to the tyrosine
one iodine → monoiodotyrosine aka MIT
two iodines → dioiodotyrosine aka DIT
Coupling → TPO couples up the mits and dits
mit + dit = t3
dit + dit = t4
atp, thyroid hormone still attached to thyroglobin → not yet free to act!
Movement Back into Cell → thyroglobin gets endocytosed
TH Release → TH gets cleaved off of thyroglobin via proteases
TH Secretion → just go free
in circulation, th is 99% bound to thyroxin binding globulin → TBG
so only like 1% is biologically active lol
th binding
binds to thyroid hormone receptor in the nucleus
forms heterodimer with retinoid x receptor → act as a transcription factor
affect metabolism, growth/development, cv/neuro function, etc
hypothyroidism s/sx
weight gain
extreme tiredness
cold intolerance
muscle cramps
severe constipation
memory issues
delayed deep tendon reflexes
hyperthyroidism s/sx
arrythmias
unexplained sweating
weight loss
termor
brisk deep tendon reflexes
hypertension
diarrhea
graves dx
autoimmune disorder, autoantibodies to TSH receptor bind and stimulate TH production
definitive diagnosis with +TRab test
but bc the abs dont respond to - feedback, will also see low TSH + high TH
s/sx
goiter → enlargement of thyroid gland as continuous stimulation induces hypertrophy of tissue
pretibial myxedema → thick red skin on feet area
fibroblast lead to dermal thickening
thyroid eye disease → fibroblasts/inflammation causes swelling and expansion of tissue behind the eyes
bulging eyes
smoking big risk factor
thyroid storm
acute, life-threatening presentation
s/sx
acute onset
hyperthermia
severe tachy
heart failure
can progress quickly to delirium, coma, and death
precipitating events → major physiologic stressors !
infection
trauma
radioactive iodine tx
surgery
hashimotos
antibodies to endogenous thyroid proteins are produced, damaging thyroid gland
antigen-presenting cells (dendritic cells, macrophages) pick up thyroid protein
t/b cells get activated and inflammatory mediators wreak havoc
b lymphocytes, t cells, macrophages infiltrate the thyroid and damage follicular cells
risk factors: women, smokers, age >50
diagnose with +TPO abs
drop in TH, but TSH high to try and increase production
amiodarone induced hypothyroidism
amiodarone looks similar to iodine, saturates the thyroid and prevent further iodide uptake
myxedema coma
life threatening, acute situation requiring immediate intervention
altered mental status leading to coma, cv collapse, respiratory failure, hypothermia
when is lio preferred
issue with deiodinases, myxedema coma
how long to use thioamides
requires 12-18 months of treatment and observation before we can decide to trial off
can stop when pt is euthyroid, graves spontaneously reverses itself
thioamde ses
maculopapular pruritic rash
agranylocytosis
dose dependent liver issues
ptu
risk of severe hepatitis
used in first trimester of pregnancy → more strongly protein bound, more likely to stay in maternal circulation
also has effects in periphery → blocks t4 to t3 conversion
preferred in thyroid storm
levo dosing regular pt
calculate ibw
dose 1.6 mcg/kg/day
start off with full dose
levo dosing for older/prolonger hypothyroidism
50 mcg/day and titrate up by 12.5-25 mcgs every 4-6 weeks
levo dosing for pt with cv disease
12.5-25 mcg/day and titrate slowly every 4-6 weeks
thioamide monitoring
tfts (t3/t4) q2-6weeks until euthyroid
then q4-6 weeks/2-3 months
tsh is unreliable to monitor early on → takes months to regain normal levels
get baseline lfts
PTH
defend against hypocalcemia → acts via cAMP (Gs) and PLC (Gq) to stimulate activity of PTHR
regulated by calcium and vitamin d
PTH in kidneys
stimulation of ca reabsorption
increase na/k/2cl in tal → more k in cell, more leakage into lumen, encourages ca reabsorption paracellularly
increases ca channel expression on apical side of distal tubule
vit d synthesis increases via stimulation of 1 alpha hydroxylase → increase absorption of ca from intestines
removes phos/bicarb transporter from apical surface of proximal tubule → phos/bicarb loss in urine!
10-15% of ca is complexed with phos, getting rid of it allows kidneys to increase free ca concentration
stopping ca from complexing with these two increases free concentrations in blood
pth in bone
stimulates bone resorption
receptor binding stimulates m-csf release → stimulates differentiation of new ocs from stem cells in bone marrow
macrophage colony stimulating factor
formation of competent oc also starts expressing/releasing RANK
so its able to activate other ocs and stimulate resorption
vit d receptor
activation increases ca receptor synthesis → leads to PTH suppression
with the same concentration, cell can be stimulated more easily
activation also suppresses PTH gene activation + decreases proliferation/differentiation of stem cells
block differentiation into mature parathyroid gland cell
osteoclasts
c for chew, break down and resorb bone
have RANK receptors and alpha/beta integrins
rank ligand is a cytokine, can be membrane-bound or secreted by oc/ob/activated lymphocytes
binding to RANK receptors induces maturation and activation
when the integrins bind to bone, they activate a signaling cascade and form a resorption pit
proton pump expression increases
expression of lysosomes containing proteolytic enzymes increases
work to demineralize bone and break down osteoid (protein bit of bone)
after the pit forms, integrins are released and oc can move on to another section of bone
osteoblasts
hey lay down in the lacuna pit and synthesize osteoid (protein part of bone)
osteoids are where mineralization occurs → pump out ca phosphate
once the lacuna gets filled, this new rebuilt bone is stronger than what was intially there
release osteoprotegrins as well → protect bone by acting as RANK receptor decoys
bind and sequester rank ligand to prevent activation
sclerostin
secreted by oc
oc → increased activity/lifespan, differentiation
ob → decreased activity, increased apoptosis/decreased life span
also inhibits osteoprotegrin production
intermittent/bolus PTH inhibits sclerostin release
which is how it has anabolic effects
sex steroids and bone
estrogens and androgens increase bone formation
increase ob differentiation and decrease oc differentiation
e also works on lymphocytes to decrease rankl expression
vit d effects
increases ca/phos reabsorption in intestines and kidneys
blocks PTH synthesis and release, as well as inhibit parathyroid growth → both normally work to increase resorption
calcitonin
prevent hypercalcemia
synthesized and released by parafollicular cells found inbetween thyroid follicles in response to high ca
increases cAMP → inhibits oc, reduces phos/ca/na reabsorption
PTRhP
Defend against hypocalcemia
parathyroid hormone related peptide → same effects as PTH but not a real hormone
but cant activate 1 alpha hydroxy and stimulate vit d production
basically PTH receptor needs prolonged stimulation in order to do that, but PTHrP only binds transiently
V important developmentally
phosphatonins
prevent hyperphosphatemia
synthesized in obs and osteocytes
regulate phos in kidney → phosphaturesis
remove na/p cotransporter from apical membrane in proximal tubule
inhibits 1 alpha h → drops vit d synth and thus drops phos reabsorption in intestine
hypercalcemia s/sx
kidney stones → kidney cant reabsorb all the ca, complexes in collecting ducts and causes damage → CKD
osteoporosis → decreases calcification of bone
peptic ulcer, pancreatitis → dk why
cns effects → alterered neuronal excitability
hr drops, conduction slows → premature ventricular contractions, arrythmias, afib, asystole
hypocalcemia s/sx
generally stem from the effect on excitable cells
extracellular ca essential for function of k leak channel → no ca, muscles/nerves are hyper-excitable
burning prickling feeling due to nerve hypersensitivity
muscle spasms → threshold for firing way too low
cramps, tetany
long qt
seizures
where are the main fracture risks
fragility fractures → bone unable to handle normal load
femur and vertebrae are esp susceptible
femur hold torso/head load → handles the most force
vertebrae → tons of trabecular bone, strength is often compromised and we see compression fractures
preventing osteo
physical activity, weight-bearing activity
fall prevention strats → get rid of tripping hazards, etc
ca/vitd supplementation
bisphos
look like phos and intercolate with bone (bind to hydroxyapatite crystals) → upon liberation via ocs, they kill them !
once the ocs die, the bisphos can reintegrate with bone and have v long duration of effect
bisphos ses
po → esophageal and gastric irritation
ci with gi dx
iv → flu like symptoms
onj → increased bone turnover in jaw + introduction of agent interfering with bone turnover → bad
have to do all dental work before starting!!!
atypical femoral fracture!! → Persistent thigh pain or groin pain, associated with long term bisphos use
serms for osteo
estrogens increase ob differentiation and decrease oc differentiation
e also works on lymphocytes to decrease rankl expression → decrease oc activity this way too
denosumab
rank ligand inhibitor
mimics osteoprotegrins structurally
work to directly decrease differentiation/maturation/activity of ocs
administered q6mos
have to use bisphos to maintain bone after you complete the one year course
pt must have normal ca or you must plan to replete during tpx
also have onj risk
given q6 months
romosozumab
sclerostin inhibitor
blocks rank ligand
decreases oc differentiation
increase opg
decrease ob apoptosis
net effect is increased bone formation and decreased bone resorption
given sq monthly, limit to 1 year use
have to follow with bisphos after two years
ses
mi/stroke/cv death
avoid within 1 year of acs
pth analogs
stimulate ob activity, anabolic
Stimulating osteoblast function and increasing bone formation
increasing gastrointestinal calcium absorption
increasing renal tubular reabsorption of calcium
require maintenance therapy with bisphos
may only use for two years → anabolic window
ses
hypercalcemia, hypercalciuria
CI in children with open growth plates → will close too early !
administer while sitting bc it can cause dizziness/lightheadedness
bmd screening
q1-2 years for women 65+
osteo non-modifiable risk factors
age >65
female sex
ethnicity
prior fractures
early menopause
osteo modifiable risk factors
smoker
low body weight
low ca/vit d
physical inactivity
diet
osteo risk stratification → high risk
prior hx of fracture, t < -2.5
bisphos or denosu
osteo risk stratification → very high risk
recent fracture within 12 months, fracturs while on therapy, t < -3
start with anabolic
bisphos renal cutoffs
renal impairment <30
avoid alen/zole when crcl <35
avoid iba/rise when crcl <30
ibandronate
only has efficacy for vertebral fractures
bisphos drug holiday
PO can consider after 5 years or 6-10 years for pt with high fracture risk
IV can consider after 3 years or 6 years for pt with high fracture risk